RELAPSED HODGKIN'S DISEASE, ADULT

Clinical trials for RELAPSED HODGKIN'S DISEASE, ADULT explained in plain language.

Never miss a new study

Get alerted when new RELAPSED HODGKIN'S DISEASE, ADULT trials appear

Sign up with your email to follow new studies for RELAPSED HODGKIN'S DISEASE, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New combo attack on stubborn blood cancer

Disease control Ongoing

This study is testing whether adding the drug ipilimumab to the approved drug nivolumab can help control Hodgkin lymphoma that has come back or stopped responding to other treatments. It will involve about 13 adults whose cancer got worse after a prior type of immunotherapy. Part…

Matched conditions: RELAPSED HODGKIN'S DISEASE, ADULT

Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

RELAPSED HODGKIN'S DISEASE, ADULT

Get alerted when new RELAPSED HODGKIN'S DISEASE, ADULT trials appear

New combo attack on stubborn blood cancer